Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE0005203947
Wed, 28.05.2025
BRAIN Biotech AG
BRAIN Biotech AG reports final half-year figures for fiscal year 2024/25
BRAINBiocatalysts experienced modest organic growth in the first half of the year
BRAINBioIncubator with high basis for comparison in the previous year
Strong liquidity maintained at €14.9 million
ZWINGENBERG, Germany, May 28, 2025 – BRAIN Biotech AG, a leading provider of [ … ]
Tue, 20.05.2025
BRAIN Biotech AG
BRAIN Biotech announces buy-out of minorities, new continental European production site, and expansion of its Baking Application Center
Breatec B.V. is now fully owned by BRAIN Biotech AG following a minority buyout
New and enlarged production site will open close to Eindhoven, NL
Expanded competence center for enzyme-based baking applications
Z [ … ]
Tue, 18.03.2025
BRAIN Biotech AG
Results of the 2025 Annual General Meeting for the 2023/24 financial year of BRAIN Biotech AG
ZWINGENBERG, March 18, 2025 – At today's Annual General Meeting of BRAIN Biotech AG (Frankfurt Stock Exchange / BNN / ISIN DE0005203947 / WKN 5203949), shareholders approved all agenda items with a broad majority. Dr. Anna C. Eichhorn and Stephen Catling [ … ]
Wed, 26.02.2025
BRAIN Biotech AG
BRAIN Biotech AG: 3M FY 24/25 - Starting the year with double digit sales growth in the core BRAINBiocatalysts division
BRAINBiocatalysts organic growth at 11 % in Q1
Quantitative guidance looking at strong growth and solid adjusted EBITDA margin for BRAINBiocatalysts in FY 2024/25
Strong cash position maintained at € 17.8 million while reducing [ … ]
Thu, 13.02.2025
BRAIN Biotech AG
Biological gold recycling: BRAIN Biotech AG collaborates with PX Group on the PX Urban Mining Initiative
Development of BioXtractor V2 pilot by BRAIN and PX Group and production of first BioGold nuggets from a local waste stream
Extension of cooperation between the two companies as part of the PX Urban Mining Initiative
PX Urban Mining Initiativ [ … ]
Wed, 15.01.2025
BRAIN Biotech AG
Annual Report 2023/24: BRAIN Biotech AG acts from a strong cash position and is confident about its growth prospects
Group cash and cash equivalents improved to € 27.2 million
Successfully closed two milestone transactions with Royalty Pharma and Akribion Therapeutics
Management sees a strong start to the new financial year
Updated mid-term tar [ … ]